Pharma Journalist 9038 posts 0 comments

Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF) announced that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after…
Read More...

atbtherapeutics, a pioneering biopharmaceutical company building an oncology pipeline using its antibody–toxin-bioengineered “atbody”, announces that it has entered a long-term…
Read More...

Tubulis, WuXi STA and WuXi Biologics announced a strategic collaboration to manufacture and advance Tubulis' next generation antibody-drug conjugates (ADCs) towards IND-enabling…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on…
Read More...

CHO Plus, an early-stage innovation company developing technology to vastly increase the productivity of cells used to manufacture therapeutic proteins, announced that it has entered…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply…
Read More...

Telix Pharmaceuticals Limited announces it has entered into an agreement with Scintec Diagnostics GmbH (‘Scintec’) to acquire TheraPharm GmbH (‘TheraPharm’), a Swiss-German…
Read More...

Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research collaboration agreement with Cedilla Therapeutics, Inc. a private biotechnology company…
Read More...

FibroGen, Inc. and Astellas Pharma Inc.  announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved EVRENZO (roxadustat) for the treatment of anemia of chronic kidney…
Read More...

Haoma Medica announced the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for…
Read More...